NCT04675619View on ClinicalTrials.gov

Evaluation of the Efficacy of Pirfenidone in Progressive Chronic Hypersensitivity Pneumonitis

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 1, 2019

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Hypersensitivity Pneumonitis
Interventions
DRUG

Oral pirfenidone

Treatment

DRUG

Standard care

Treatment

Trial Locations (1)

44555

Eman Shebl, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT04675619 - Evaluation of the Efficacy of Pirfenidone in Progressive Chronic Hypersensitivity Pneumonitis | Biotech Hunter | Biotech Hunter